摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-萘甲酰胺,1-氨基- | 1013-29-2

中文名称
2-萘甲酰胺,1-氨基-
中文别名
——
英文名称
1-Amino-naphthoesaeure-(2)-amid
英文别名
1-Amino-2-naphthamid;1-Amino-2-naphthalenecarboxamide;1-aminonaphthalene-2-carboxamide
2-萘甲酰胺,1-氨基-化学式
CAS
1013-29-2
化学式
C11H10N2O
mdl
——
分子量
186.213
InChiKey
HCOJHOQYVZPATP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    194.5 °C
  • 沸点:
    403.8±20.0 °C(Predicted)
  • 密度:
    1.288±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    69.1
  • 氢给体数:
    2
  • 氢受体数:
    2

SDS

SDS:d483d13b1161ce124928d0bdc5f2e6ef
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer
    申请人:EPIZYME, INC.
    公开号:US10266526B2
    公开(公告)日:2019-04-23
    The present disclosure provides carboxamides and sulfonamides having Formula (I): and the pharmaceutically acceptable salts and solvates thereof, wherein A, Y, B, X, and Z are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of SMYD proteins such as SMYD3 or SMYD2. Compounds of the present disclosure are especially useful for treating cancer.
    本公开提供了具有式(I)的羧酰胺类和磺酰胺类化合物:及其药学上可接受的盐和溶剂,其中A、Y、B、X和Z的定义如说明书所述。本公开还涉及使用式(I)化合物治疗对 SMYD 蛋白如 SMYD3 或 SMYD2 的阻断有反应的紊乱。本公开的化合物尤其适用于治疗癌症。
  • Schroeder et al., Chemische Berichte, 1965, vol. 98, p. 2556
    作者:Schroeder et al.
    DOI:——
    日期:——
  • SMYD Inhibitors
    申请人:EPIZYME, INC.
    公开号:US20170355695A1
    公开(公告)日:2017-12-14
    The present disclosure provides carboxamides and sulfonamides having Formula (I): and the pharmaceutically acceptable salts and solvates thereof, wherein A, Y, B, X, and Z are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of SMYD proteins such as SMYD3 or SMYD2. Compounds of the present disclosure are especially useful for treating cancer.
  • SMYD INHIBITORS
    申请人:EPIZYME, INC.
    公开号:US20190322660A1
    公开(公告)日:2019-10-24
    The present disclosure provides carboxamides and sulfonamides having Formula (I): and the pharmacentically acceptable salts and solvates thereof, wherein A, Y, B, X, and Z are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of SMYD proteins such as SMYD3 or SMYD2. Compounds of the present disclosure are especially useful for treating cancer.
  • 유기발광 화합물 및 이를 포함하는 유기전계발광소자
    申请人:Samsung Display Co., Ltd. 삼성디스플레이 주식회사(120120164552) Corp. No ▼ 134511-0187812
    公开号:KR20150043571A
    公开(公告)日:2015-04-23
    본 발명은 하기 [화학식 1-1] 내지 [화학식 1-2]로 표시되는 유기발광 화합물에 관한 것으로서, 이를 채용한 유기전계발광소자느 발광 효율이 우수하면서도 동시에 저전압 구동이 가능하여 향상된 전력효율과 장수명 특성을 갖는다. [화학식 1-1] [화학식 1-2]
    本发明涉及如下式[化学式1-1]至[化学式1-2]所示的有机发光化合物,采用该化合物的有机电致发光器件具有优异的发光效率,同时还能实现低电压驱动,从而具有改善的功率效率和长寿命特性。[化学式1-1] [化学式1-2]
查看更多